Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease-Reference-Cited by-同舟云学术

Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease

Published:2022-05 Issue:5 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Kim Eun Na¹,Do Hyo‐Sang²,Jeong Hwangkyo³,Kim Taeho⁴,Heo Sun Hee²,Kim Yoo‐Mi⁵,Cheon Chong Kun⁶,Lee Yena⁷,Choi Yunha⁷,Choi In Hee⁸,Choi Jeongmin²,Yoo Han‐Wook⁷,Kim Chong Jai⁹,Zimran Ari¹⁰,Kim Kyunggon¹¹,Lee Beom Hee⁷¹²

Affiliation:

1. Computational Biology Program Department of Biomedical Engineering Oregon Health and Science University Portland Oregon USA

2. Asan Institute for Life Sciences Asan Medical Center Seoul Republic of Korea

3. Department of Biomedical Sciences University of Ulsan College of Medicine Seoul Republic of Korea

4. AniCom Therapeutics Seoul Republic of Korea

5. Department of Pediatrics Chungnam National University Sejong Hospital Sejong Republic of Korea

6. Department of Pediatrics Pusan National University School of Medicine Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital Yangsan Republic of Korea

7. Department of Pediatrics Asan Medical Center Children's Hospital University of Ulsan College of Medicine Seoul Republic of Korea

8. Department of Genetic Counseling University of Ulsan College of Medicine Seoul Republic of Korea

9. Department of Pathology Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

10. The Hebrew University Hadassah Medical School Jerusalem Israel

11. Department of Convergence Medicine Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

12. Medical Genetics Center Asan Medical Center University of Ulsan College of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.862

Reference10 articles.

1. Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model

2. Immunological Cells and Functions in Gaucher Disease

3. Value of Glucosylsphingosine (Lyso-Gb1) as a Biomarker in Gaucher Disease: A Systematic Literature Review

4. Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials

5. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease;Human Molecular Genetics;2024-08-05

2. A 10‐year follow‐up of high‐dose ambroxol treatment combined with enzyme replacement therapy for neuropathic Gaucher disease;American Journal of Hematology;2024-04

3. A Brazilian Rare-Disease Center’s Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF;International Journal of Molecular Sciences;2024-03-01

4. Ultra‐Small ATP‐Decorated Gold Nanoparticles for Targeting Amyloid Fibrils in Neurodegenerative Diseases;Advanced Functional Materials;2023-12-22

5. Exploring Pro-Inflammatory Immunological Mediators: Unraveling the Mechanisms of Neuroinflammation in Lysosomal Storage Diseases;Biomedicines;2023-04-01